NURIX THERAPEUTICS, INC.: accounts_payable
| Value | {"amount": 4525000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-05-31) |
| Status | current |
| Entity | NURIX THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:43:20.797219+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/cd6fd05f-3e66-43cf-800c-d5c0d75596b6
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001549595-23-000040 · Open the official SEC filing →Retrieved: 2026-08-19T15:43:20.797219+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001549595/accounts-payable/2023-05-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/cd6fd05f-3e66-43cf-800c-d5c0d75596b6
History
- no predecessors — first report